The Swiss Leader Index (SLI) was launched in 2007 as an alternative to Switzerland’s blue-chip index SMI. It is a benchmark tracking the 30 largest and most liquid stocks on the Swiss stock market. Unlike the Swiss Market Index (SMI), which is heavily weighted toward its top constituents, the SLI applies an upper weight limit, capping the maximum weight of the four largest companies at 9%. In addition, the weighting of the other securities is limited to 4.5%.
The structure is designed to prevent excessive dominance by a few major firms and allows for broader diversification across Switzerland’s leading industries.
The SLI includes a mix of multinational corporations and domestic leaders spanning sectors such as pharmaceuticals, financial services, consumer goods, and industrials. Healthcare stocks currently make up 32% of the index, with financials in second at 25%. Given Switzerland’s reputation for stability and economic resilience, the index is widely followed.
Swiss Leader Index Performance
After a significant dip in 2022, the SLI has performed extremely well, recently reaching new highs. Swiss stocks are considered by many to be attractive investments as the country has a strong economy and political stability. In addition, many of the names listed have a global reach, particularly in sectors like pharmaceuticals and finance.
| Period | Performance (as of 28/02/2025) |
|---|---|
| 1-year | +13.68% |
| 3-years | +3.62% |
| 7-years | +5.34% |
| 15-years | +5.06% |
Swiss Leader Index Top 10 Companies
| Company | Weight (% as of 28/02/2025) |
|---|---|
| Roche | 9.67% |
| Nestle | 9.61% |
| Novartis | 9.16% |
| UBS | 8.92% |
| Richemont | 5.59% |
| Holcim | 4.51% |
| Zurich Insurance | 4.47% |
| Swiss RE | 4.42% |
| Alcon | 4.35% |
| Lonza | 4.28% |
Swiss Stocks Forecast
The Bull Argument: Those bullish on, or those holding a favourable view of Swiss equities will generally highlight the stability and defensive qualities of many SLI constituents. Switzerland is home to leading pharmaceutical and consumer goods companies, which generate consistent earnings regardless of economic cycles. In addition, strong global demand for Swiss precision manufacturing, insurance services, and luxury goods provides long-term support for many index members. Analysts also point to Switzerland’s stable regulatory environment, favourable tax policies, and innovation-driven economy as key factors supporting continued growth.
The Bear Argument: While the factors above provide a strong case for investors to gain exposure to Swiss equities, especially the well-established names, there are also risks to consider. For example, on the downside, critics caution that Swiss equities can be impacted by currency fluctuations, particularly the strength of the Swiss franc, which may reduce export competitiveness. Furthermore, while defensive sectors such as healthcare and consumer staples offer stability, they may underperform cyclical sectors during global economic recoveries. Geopolitical uncertainties and potential changes to Swiss-EU trade relations could also pose challenges for certain companies, while the uncertainty brought about due to tariffs implemented and threatened by the new US administration are also factors to watch.
Our View: ETFs tracking the SLI Swiss Leader Index present an appealing option for investors seeking broad exposure to Switzerland’s strongest companies while maintaining diversification.
As mentioned in the bull case above, Switzerland’s reputation for economic resilience, innovation, and global competitiveness make well-known Swiss stocks a solid choice for long-term investors. While short-term market fluctuations may arise due to currency movements or broader economic conditions, the index’s defensive sector composition offers relative stability compared to more volatile indices. As a result, the market can be a solid choice.
Who Should Invest in Swiss Stocks
For many, the SLI Swiss Leader Index holds an attractive basket of stocks. For investors interested in gaining exposure to the SLI, ETFs tracking Swiss equities, such as the iShares SLI ETF, provide an easy way to invest in the index.
For those interested in investing in leading Swiss stocks, certain investor profiles will be better suited:
Long-Term Investors: Those seeking stable, high-quality companies with consistent earnings and dividend payouts.
Defensive Investors: Given its strong exposure to pharmaceuticals, consumer goods, and financials, the SLI is well-suited for those prioritising lower volatility.
Diversification Seekers: The equal-weighted structure ensures broad representation across Switzerland’s key industries.
European Market Investors: Those looking to complement Eurozone equity exposure with Switzerland’s more resilient market.
